Viewing Study NCT00000632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-28 @ 10:56 PM
Study NCT ID: NCT00000632
Status: COMPLETED
Last Update Posted: 2021-11-02
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None HIV Seronegativity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccines, Synthetic View
None Drug Evaluation View
None Adjuvants, Immunologic View
None AIDS Vaccines View
None HIV Preventive Vaccine View